Acute Effects of Tribulus Terrestris on Anaerobic Power and Sprint Performance in Combat Sport Athletes

NCT ID: NCT07164547

Last Updated: 2025-09-10

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

28 participants

Study Classification

INTERVENTIONAL

Study Start Date

2025-03-21

Study Completion Date

2025-08-15

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

This study aims to investigate the acute effects of Tribulus terrestris supplementation on anaerobic performance and sprint times in trained male combat sport athletes. A total of 28 athletes from kickboxing, Muay Thai, and taekwondo disciplines will participate in a randomized, double-blind, placebo-controlled, crossover trial.

Participants will ingest either a single oral dose of 625 mg Tribulus terrestris (40% saponins) or a placebo 60 minutes before performing performance tests. The performance assessments will include a 30-second Wingate anaerobic cycling test and 20 m and 100 m sprint tests using photocell timing gates. After a wash-out period, participants will cross over to the alternate condition.

The primary outcomes are peak power and mean power from the Wingate test and sprint times over 20 m and 100 m.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

This trial is designed to evaluate the acute ergogenic potential of Tribulus terrestris supplementation in combat sport athletes. Tribulus terrestris has traditionally been marketed as a natural testosterone booster and performance enhancer, yet its acute effects on high-intensity exercise performance remain unclear.

Design and Methods

Participants: 28 trained male athletes (Kickboxing n=12, Muay Thai n=10, Taekwondo n=6), aged 18-30 years, with at least 2 years of competitive training experience.

Design: Randomized, double-blind, placebo-controlled, crossover.

Intervention: A single dose of 625 mg Tribulus terrestris (40% saponins) or matched placebo (cellulose). Supplements will be ingested 60 minutes before testing.

Procedures: After a standardized warm-up, participants will complete a 30-second Wingate test on a Monark cycle ergometer (resistance = 10% body mass) to measure peak power, mean power, and fatigue index. Following 10 minutes of recovery, participants will perform 20 m and 100 m sprint tests using double-beam photocells (Witty timing system). Each participant will perform both supplementation conditions with a ≥72 h wash-out.

Outcomes Primary outcomes: Wingate peak power (W, W/kg), mean power (W, W/kg). Secondary outcomes: 20 m and 100 m sprint times (s).

Ethics: Approved by the Ethics Committee of Atatürk University (Protocol No: E-70400699-000-2500104927). Written informed consent will be obtained from all participants.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Anaerobic Power Sprint Performance

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

CROSSOVER

This is a randomized, double-blind, placebo-controlled, crossover trial in which all participants received both Tribulus terrestris and placebo supplementation with a wash-out period in between conditions.
Primary Study Purpose

TREATMENT

Blinding Strategy

QUADRUPLE

Participants Caregivers Investigators Outcome Assessors
Participants, investigators, care providers, and outcome assessors were blinded to group allocation. Supplements were prepared in identical capsules to ensure blinding integrity.

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Tribulus Terrestris

A single oral dose of 625 mg Tribulus terrestris extract (40% saponins) given 60 minutes before exercise testing.

Group Type EXPERIMENTAL

Tribulus terrestris extract

Intervention Type DIETARY_SUPPLEMENT

625 mg oral capsule (40% saponins), single dose

Placebo

Visually identical cellulose capsule given 60 minutes before exercise testing.

Group Type PLACEBO_COMPARATOR

Cellulose capsule (placebo)

Intervention Type OTHER

Oral cellulose capsule, identical in appearance

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Tribulus terrestris extract

625 mg oral capsule (40% saponins), single dose

Intervention Type DIETARY_SUPPLEMENT

Cellulose capsule (placebo)

Oral cellulose capsule, identical in appearance

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Male athletes aged 18-30 years
* Engaged in combat sports (kickboxing, Muay Thai, or taekwondo)
* Minimum 2 years of continuous training experience
* Training at least 4 sessions per week
* Free from injury or illness at the time of testing
* Provided written informed consent

Exclusion Criteria

* Use of ergogenic supplements, anabolic steroids, or hormonal treatments within the past 3 months
* Consumption of caffeine, alcohol, or performance-enhancing substances within 24 hours before testing
* Current musculoskeletal injury or medical condition that may limit performance
* Any chronic disease or contraindication to high-intensity exercise
Minimum Eligible Age

18 Years

Maximum Eligible Age

30 Years

Eligible Sex

MALE

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Salih ÇABUK

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Salih ÇABUK

Research Assistant

Responsibility Role SPONSOR_INVESTIGATOR

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Atatürk University, Sports Science Laboratory

Erzurum, Erzurum, Turkey (Türkiye)

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Turkey (Türkiye)

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

E-70400699-050.02.04-250010269

Identifier Type: OTHER

Identifier Source: secondary_id

ETU-TRIBULUS-2025

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.